# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-060682
Filing Date
2023-11-08
Accepted
2023-11-08 07:29:45
Documents
61
Period of Report
2023-09-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | tngx-20230930.htm iXBRL | 10-Q | 2255850
2 | EX-31.1 | tngx-ex31_1.htm | EX-31.1 | 17394
3 | EX-31.2 | tngx-ex31_2.htm | EX-31.2 | 17319
4 | EX-32.1 | tngx-ex32_1.htm | EX-32.1 | 8237
5 | EX-32.2 | tngx-ex32_2.htm | EX-32.2 | 8228
| Complete submission text file | 0000950170-23-060682.txt |  | 7614948

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
6 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | tngx-20230930_cal.xml | EX-101.CAL | 43986
7 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | tngx-20230930_pre.xml | EX-101.PRE | 258403
8 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | tngx-20230930_lab.xml | EX-101.LAB | 360638
9 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | tngx-20230930_def.xml | EX-101.DEF | 171439
10 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | tngx-20230930.xsd | EX-101.SCH | 39375
55 | EXTRACTED XBRL INSTANCE DOCUMENT | tngx-20230930_htm.xml | XML | 1414664

Mailing Address 201 BROOKLINE AVENUE SUITE 901 BOSTON MA 02215
Business Address 201 BROOKLINE AVENUE SUITE 901 BOSTON MA 02215 (857) 320-4900
Tango Therapeutics, Inc. (Filer) CIK: 0001819133 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39485 | Film No.: 231385956
SIC: 2834 Pharmaceutical Preparations